Company

Celaid Therapeutics

Biotechnology Jp 14 employees

Employees: 14
Contacts: 2
Emails: 2
Phones: 1

celaidtx.com LinkedIn Crunchbase

Celaid Therapeutics Overview

Headquarters: Jp
Website: celaidtx.com
Industry: Biotechnology
Employees: 14
Founded: 2020
Funding: 3.0M

Keywords

再生医療バイオテクノロジー細胞治療造血幹細胞試薬・培地がん領域

About Celaid Therapeutics

Celaid Therapeutics is a Japan-based biotechnology company, which has developed a platform technology to efficiently expand hematopoietic stem cells ex vivo without choosing its origins, including bone marrow, cord blood, or peripheral blood. By using the novel technology, we are developing a cell therapy product that brings HSC transplantation to the next level and helps patients with blood disorders. Our technology has many potential applications including gene/cell therapy that utilize gene editing on HSC. Our mission is to improve QOL of patients, their families, and HSC donors all over the world.

Celaid Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Celaid Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Dean Merkel	Manager of Global Business Development at Celaid Therapeutics	Kagoshima, Japan	Email
Nobuyuki Arakawa	President & CEO at Celaid Therapeutics - Developing Cell Therapy for Patients with Blood Disorders - We Are Seeking Some Partners Like Business		View
Asako Uchiyama	Chief Development Officer at Celaid Therapeutics - Developing Cell Therapy Products for Patients with Blood Disorder		View
Tomoyo Hamada	Celaid, Senior Manager	Tokyo, Japan	Email Phone